ORBIMED ADVISORS LLC Q2 2023 Filing
Filed August 14, 2023
Portfolio Value
$5518.9T
Holdings
121
Report Date
Q2 2023
Filing Type
13F-HR
All Holdings (121 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | ALKSALKERMES PLC | 151,400 | $4.7T | 0.09% | |
| 102 | NSPRINSPIREMD INC | 1,860,405 | $4.7T | 0.08% | |
| 103 | VIGLVIGIL NEUROSCIENCE INC | 448,891 | $4.2T | 0.08% | |
| 104 | ARWRARROWHEAD PHARMACEUTICALS IN | 117,000 | $4.2T | 0.08% | |
| 105 | APLMAPOLLOMICS INC | 662,561 | $3.8T | 0.07% | |
| 106 | BCABBIOATLA INC | 1,156,175 | $3.5T | 0.06% | |
| 107 | CMMBCHEMOMAB THERAPEUTICS LTD | 2,241,274 | $2.9T | 0.05% | |
| 108 | —SYNLOGIC INC | 6,029,995 | $2.6T | 0.05% | |
| 109 | RVNCEURREVANCE THERAPEUTICS INC | 100,000 | $2.5T | 0.05% | |
| 110 | EPIEURESSA PHARMA INC | 921,940 | $2.5T | 0.05% | |
| 111 | AFIBACUTUS MED INC | 2,648,386 | $2.4T | 0.04% | |
| 112 | —ELEVATION ONCOLOGY INC | 1,500,000 | $2.3T | 0.04% | |
| 113 | BOLT1EURBOLT BIOTHERAPEUTICS INC | 1,541,000 | $2.0T | 0.04% | |
| 114 | TARAPROTARA THERAPEUTICS INC | 772,584 | $1.8T | 0.03% | |
| 115 | PHGEBIOMX INC | 4,553,489 | $1.6T | 0.03% | |
| 116 | CALCCALCIMEDICA INC | 297,380 | $1.2T | 0.02% | |
| 117 | TGTXTG THERAPEUTICS INC | 45,800 | $1.1T | 0.02% | Call |
| 118 | HRTXHERON THERAPEUTICS INC | 802,700 | $931.1B | 0.02% | |
| 119 | —SINGULAR GENOMICS SYSTEMS IN | 540,697 | $448.8B | 0.01% | |
| 120 | —HARPOON THERAPEUTICS INC | 621,218 | $441.1B | 0.01% | |
| 121 | ALTALTIMMUNE INC | 100,000 | $353.0B | 0.01% | |
| 122 | NKTREURNEKTAR THERAPEUTICS | 515,000 | $296.2B | 0.01% | Call |
PreviousPage 2 of 2